Impact of pre-acclimatization and smart-monitoring technologies on safety and success on Everest- a narrative review.
DOI:
https://doi.org/10.12775/QS.2026.72.75416Keywords
Mount Everest, Pre-acclimatization, Hypoxia conditioning, Smart-monitoring, Acute mountain sickness, Summit successAbstract
Background: Mount Everest represents the ultimate human physiological frontier. Traditionally restricted to elite athletes with exceptional natural tolerance to hypoxia, high-altitude mountaineering has undergone a paradigm shift driven by technological innovation. These advancements act as a "great equalizer," allowing individuals with limited experience or physiological adaptability to attempt the summit with higher success rates.
Objective: This narrative review synthesizes contemporary evidence (2012–2026) regarding how pre-acclimatization and smart-monitoring technologies function as core drivers of this accessibility shift.
Methods: A targeted search of PubMed, Scopus, and Google Scholar was performed using Boolean operators. Twenty-one key publications were qualitatively synthesized, focusing on hypoxia conditioning (HC) protocols, wearable physiological telemetry (SpO2, ECG), and expedition statistics derived from the Himalayan Database.
Results: While demographics have shifted toward older and less experienced climbers, summit success probabilities have nearly doubled since 1990. Pre-acclimatization via normobaric HC (200–300 hours) effectively reduces the risk of Acute Mountain Sickness (AMS) and permits compressed schedules, thereby mitigating high-altitude cachexia and muscle depletion. Smart monitoring has uncovered critical "silent" risks, such as asymptomatic acquired long QT syndrome in 24% of climbers above 7,900 m. Furthermore, climate change provides a subtle assist through the "thicker air" phenomenon, although weather volatility remains a significant challenge.
Conclusions: Technology has transformed Everest mountaineering into a managed, precision-guided endeavor where safety and success are mediated by innovation rather than innate physiology. The industry should evolve toward mandatory medical screening and risk management standards based on objective telemetry from wearable health devices.
References
Burtscher, J., Gatterer, H., Beidleman, B. A., Burtscher, M. (2025). Dexamethasone for prevention of AMS, HACE, and HAPE and for limiting impairment of performance after rapid ascent to high altitude: a narrative review. Military Medical Research, 12, 48. https://doi.org/10.1186/s40779-025-00634-y
Burtscher, J., Hüfner, K., Gatterer, H., Pichler-Hefti, J., Hefti, U., Tannheimer, M., Kleinsasser, A., Hackett, P., Burtscher, M. (2026). Time requirements of pre-acclimatization at simulated altitude to prevent acute mountain sickness. Journal of Travel Medicine, 33(3), taag009.
https://doi.org/10.1093/jtm/taag009
Burtscher, M., Millet, G. P., Burtscher, J. (2022). Hypoxia conditioning for high-altitude pre-acclimatization. Journal of Science in Sport and Exercise, 4, 331–345. https://doi.org/10.1007/s42978-021-00150-0
Cai, C., Ni, G., Chen, L., Deng, C., Chai, S., Wang, R., Zhang, R., Luo, F., Ge, R. (2026). Altitude hypoxia and hypoxemia: pathogenesis and management. Signal Transduction and Targeted Therapy, 11, 27. https://doi.org/10.1038/s41392-025-02531-1
Choroszewicz, P., Dobosiewicz, A. M., Badiuk, N. (2020). Acetazolamide in the prevention of altitude disease. Pedagogy and Psychology of Sport, 6(2), 95–103. https://doi.org/10.12775/PPS.2020.06.02.009
Dorji, T., Giri, S., Tshering, U., LeVine, S., Tshering, U., Chhetri, S., Dhakal, N., Gaikwad, S. N., Flaherty, G. T., Lucero-Prisno III, D. L., McIntosh, S. (2023). Challenges in the management of high-altitude illnesses and emergencies in Bhutan and Nepal. Travel Medicine and Infectious Disease, 56, 102660. https://doi.org/10.1016/j.tmaid.2023.102660
Ellerton, J., Sheets, A., McLaughlin, K., Paal, P. (2026). Rescue at extreme altitude: managing the ethical considerations in the language of risk management. An International Commission for Alpine Rescue position paper. High Altitude Medicine & Biology, 27(2), 117–122. https://doi.org/10.1177/15578682251400732
Gordon, E. C., Dodds, C. (2023). High altitude, enhancement, and the 'spirit of sport'. Journal of the Philosophy of Sport, 50(1), 63–82. https://doi.org/10.1080/00948705.2023.2168679
Hou, S., Jiang, J., Huang, Y., Liang, Y., Zhou, X., Li, L., (2026). The independent predictive effect of insomnia symptoms before high-altitude exposure on acute mountain sickness: an observational study of healthy volunteers at 2726 m. Frontiers in Psychiatry, 17, 1765494. https://doi.org/10.3389/fpsyt.2026.1765494
Huey, R. B., Carroll, C., Salisbury, R., Wang, J. L. (2020). Mountaineers on Mount Everest: Effects of age, sex, experience, and crowding on rates of success and death. PLoS One, 15(8), e0236919. https://doi.org/10.1371/journal.pone.0236919
Jia, N., Chen, C., Chen, Q., Liu, J., Shen, Z., Liu, Y., Pei, C., Wang, Y., Huang, D., Wang, F., He, Y., Wang, Z. (2026). Acute high-altitude illness: risk factors, susceptibility prediction, and personalized prevention and treatment. Frontiers in Medicine, 12, 1735083. https://doi.org/10.3389/fmed.2025.1735083
Karpęcka-Gałka, E., Frączek, B. (2024). Nutrition, hydration, and supplementation considerations for mountaineers in high-altitude conditions: a narrative review. Frontiers in Sports and Active Living, 6, 1435494. https://doi.org/10.3389/fspor.2024.1435494
Karpęcka-Gałka, E., Mazur-Kurach, P., Szyguła, Z., Frączek, B. (2023). Diet, supplementation and nutritional habits of climbers in high mountain conditions. Nutrients, 15(19), 4219. https://doi.org/10.3390/nu15194219
Li, L., Zhou, Y., Zou, S., Wang, Y. (2023). The effects of high-altitude mountaineering on cognitive function in mountaineers: a meta-analysis. International Journal of Environmental Research and Public Health, 20(6), 5101. https://doi.org/10.3390/ijerph20065101
Matthews, T., Perry, L. B., Lane, T. P., Elmore, A. C., Khadka, A., Aryal, D., Shrestha, D., Tuladhar, S., Baidya, S. K., Gajurel, A., Potocki, M., Mayewski, P. A. (2020). Into thick(er) air? Oxygen availability at humans' physiological frontier on Mount Everest. iScience, 23, 101718. https://doi.org/10.1016/j.isci.2020.101718
Olejarz, Z., Nowak, K., Drygała, Z., Wyrwał, J., Zielińska, Z., Słowik, M., Nowak, K., Nieć, M., Gierlach, K., Krasuska, M. (2024). Examination of novel diagnostic approaches and contemporary strategies for preventing acute mountain sickness. Journal of Education, Health and Sport, 54, 141-157. https://doi.org/10.12775/JEHS.2024.54.011
Pilgrim, T., Ryffel, C., Sherpa, P. P., Sherpa, T., Sherchand, O., Galuszka, O., Odening, K. E., Rothenbuhler, M., Reichlin, T., Sherpa, K. (2024). QT prolongation and acquired long QT syndrome in climbers on Mount Everest. JACC: Clinical Electrophysiology, 10(11), 2509–2511. https://doi.org/10.1016/j.jacep.2024.07.012
Szymczak, R. K., Marosz, M., Grzywacz, T., Sawicka, M., Naczyk, M. (2021). Death zone weather extremes mountaineers have experienced in successful ascents. Frontiers in Physiology, 12, 696335. https://doi.org/10.3389/fphys.2021.696335
Wagner, D. R. (2012). Medical and sporting ethics of high altitude mountaineering: the use of drugs and supplemental oxygen. Wilderness & Environmental Medicine, 23, 205–206. https://doi.org/10.1016/j.wem.2012.03.011
Westhoff, J. L., Koepsell, T. D., & Littell, C. T. (2012). Effects of experience and commercialization on survival in Himalayan mountaineering: retrospective cohort study. BMJ, 344, e3782. https://doi.org/10.1136/bmj.e3782
Zhao, C., Zhao, X., Ma, Y., Liu, Y., Chen, R., Sha, L. (2024). Dynamics in the prevalence and clinical manifestations of acute mountain sickness of different ascent protocols during high-altitude exposure. Frontiers in Public Health, 12, 1472935. https://doi.org/10.3389/fpubh.2024.1472935
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Agata Sobczak, Maja Kowalczyk, Magdalena Wolff, Lena Głuszkiewicz, Kalina Kreft, Anna Waldman
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 0
Number of citations: 0
